The Calmer Company (ASX:CCO) is getting major traction with its Kava products

Calmer Company (ASX:CCO) We spoke with Dr. Anthony Noble, CEO of The Calmer Company (ASX:CCO), about…

Nyrada (ASX:NYR) is making solid progress going into 2025: Interview with CEO James Bonnar

Nyrada (ASX:NYR) We talked to James Bonnar, CEO of Nyrada (ASX: NYR), about the company’s remarkable…

BrainChip is set for a big 2025: Interview with CEO

BrainChip (ASX:BRN) We spoke to Sean Hehir, CEO of BrainChip (ASX:BRN), about commercial opportunities in the…

Highfield Resources’ (ASX:HFR) Muga Potash project is a company maker!

Highfield Resources (ASX:HFR) We spoke to Ignacio Salazar, CEO of Highfield Resources (ASX:HFR), about the recent…

Island Pharmaceuticals (ASX:ILA) is in Phase 2 with ILA-101

Island Pharmaceuticals (ASX:ILA) We spoke to Dr Paul MacLeman, Executive Chairman of Island Pharmaceuticals (ASX:ILA), about…

4DS Memory (ASX:4DS) is building momentum going into 2025

4DS Memory (ASX:4DS) We spoke with Peter Himes, CTO of 4DS Memory (ASX:4DS), about the company’s…

BluGlass (ASX:BLG): Interview with CEO Jim Haden

BluGlass (ASX:BLG) We spoke with BluGlass CEO Jim Haden, who was in Sydney for Semiconductor Australia…

Resouro Strategic Metals (ASX:RAU): Interview with CEO Chris Eager

Resouro Strategic Metals (ASX:RAU) We spoke with Chris Eager, CEO of Resouro Strategic Metals (ASX:RAU), about…

Rhythm Biosciences (ASX: RHY): Interview with CEO David Atkins

Rhythm Biosciences (ASX:RHY) We spoke to Dr. David Atkins, CEO of Rhythm Biosciences (ASX: RHY), about…

AFT Pharmaceuticals (ASX:AFP) at the Pitt Street Research Life Sciences Conference 2024

AFT Pharmaceuticals (ASX:AFP) AFT Pharmaceuticals (ASX:AFP) CEO Dr. Harley Atkinson presented at the Pitt Street Research…

Island Pharmaceuticals (ASX:ILA) spoke at the Pitt Street Research Life Sciences Conference 2024

Island Pharmaceuticals (ASX:ILA) Island Pharmaceuticals (ASX:ILA) Executive Chairman Dr. Paul MacLeman spoke at the Pitt Street…

Cann Group (ASX:CAN) at the Pitt Street Research Life Sciences Conference 2024

Cann Group (ASX:CAN) Cann Group (ASX:CAN) Jenni Pilcher spoke at the Pitt Street Research Life Sciences…

Actinogen (ASX:ACW) presented at the Pitt Street Research Life Science Conference 2024

Actinogen (ASX:ACW) Dr. Steve Gourlay, MD & CEO of Actinogen (ASX:ACW), presented at the Pitt Street…

Graphite play Black Rock Mining (ASX:BKT) has got its ducks in a row in 2024

Black Rock Mining (ASX:BKT) We spoke with John de Vries, CEO of Black Rock Mining (ASX:…

Invion (ASX:IVX) at the Pitt Street Research Life Sciences Conference 2024

Invion (ASX:IVX) Thian Chew, Executive Chair and CEO of Invion (ASX:IVX), presented at the Pitt Street…

Percheron Therapeutics (ASX:PER) presented at the Pitt Street Research Life Sciences Conference 2024

Percheron Therapeutics (ASX:PER) Dr James Garner, MD & CEO of Percheron Therapeutics (ASX:PER), presented at the…

Proteomics International Laboratories (ASX:PIQ) presenting at the Pitt Street Research Life Sciences Conference 2024

Proteomics International Laboratories Proteomics International Laboratories‘ (ASX:PIQ) MD, Dr Richard Lipscombe, spoke at the Pitt Street…

MTM Critical Metals (ASX: MTM) is going places! Interview with CEO Michael Walshe

MTM Critical Metals CEO Michael Walshe chats with us! We spoke to Michael Walshe, CEO of…